MHRA authorises UCB’s bimekizumab through new post-Brexit licensing pathway

MHRA authorises UCB’s bimekizumab through new post-Brexit licensing pathway

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for UCB’s Bimzelx®▼(bimekizumab) for the treatment of adults with moderate to severe...
Generic astma & COPD treatment available to UK patients

Generic alternative treatment for asthma & COPD available in UK

Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin) has announced that following Marketing Authorisation earlier this year, it has launched Luforbec...
Novartis' Rydapt (mydostaurin) approved

Novartis’ Rydapt®▼ receives NICE recommendation

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination recommending Novartis' Rydapt®▼ (midostaurin) for the treatment of aggressive...
Merck partners with start-up for neurostimulator development

Merck partners with start-up for neurostimulator development

Merck has announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH – a B. Braun subsidiary and early-stage start-up company based...
Avacta Group, the clinical stage oncology drug company has announced the appointment of Dr Mark Goldberg as Non-executive Director to the Board

Avacta appoints Dr Mark Goldberg as Non-Executive Director

Avacta Group, the clinical stage oncology drug company has announced the appointment of Dr Mark Goldberg as Non-executive Director to the Board with immediate...
Weleda partners with Esko to increase pharmaceutical packaging efficiency

Weleda partners with Esko to increase pharmaceutical packaging efficiency

Integrated software solutions expert, Esko, has teamed up with Weleda to streamline its pharmaceutical packaging process through the integration of Esko WebCenter with Content Management.  Previously, Weleda had used a content management system (CMS) to manage...
Oxford Vaccine Group team begin Phase I trial of new plague vaccine

Oxford Vaccine Group team begin Phase I trial of new plague vaccine

Researchers at the University of Oxford have launched a Phase 1 trial to test a new vaccine against plague, based on the ChAdOx1 adenovirus...
Almirall’s lebrikizumab shows improvements in Phase III trials  

Almirall’s lebrikizumab shows improvements in Phase III trials  

Almirall has announced that two Phase III clinical trials have demonstrated that lebrikizumab, its treatment for moderate-to-severe atopic dermatitis (AD), has shown significant improvements...
Early phase lung drug trial proves hopeful for heart failure patients

Early phase lung drug trial proves hopeful for heart failure patients

An early phase trial, funded by the National Institute for Health Research (NIHR), has shown that a drug currently used to treat lung fibrosis...
LINK Medical appoints Maria Hortlund to strengthen its RWE department

LINK Medical appoints Maria Hortlund to strengthen its RWE department

LINK Medical, a contract research organization (CRO) providing product development services for pharmaceutical and medical device industries across Northern Europe, has announced that Maria...

Latest articles

PM Society Digital Awards Winners 2021

PM Society Digital Awards Winners 2021

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology

New patient coalition launched for digital health technology

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
How to digitalise MSL teams for increased efficiency

How to digitalise MSL teams for increased efficiency

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
PM Society Digital Awards Winners 2021

PM Society Digital Awards Winners 2021

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology

New patient coalition launched for digital health technology

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the...
How to digitalise MSL teams for increased efficiency

How to digitalise MSL teams for increased efficiency

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription